Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain zaps and swallow drills: new combo therapy for tube patients

NCT ID NCT07381946

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a non-invasive brain stimulation technique (rTMS) combined with standard swallowing exercises can help patients who have trouble swallowing after a breathing tube is removed. Sixty adults will be randomly assigned to either swallowing training alone or swallowing training plus rTMS. The goal is to improve oral feeding ability and reduce complications like pneumonia.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Sep 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age greater than 18 years; 2. Tracheal intubation for more than 48 hours; 3. Clear consciousness at the time of assessment, able to understand and follow the simple instructions of the researchers; 4. Patients have dysphagia, and the Functional Oral Intake Scale (FOIS) assessment is at levels Exclusion Criteria: 1. Previous history of dysphagia; 2. Undergoing tracheotomy; 3. History of epilepsy; 4. Having metal implants in the brain; 5. Implanted with a cardiac pacemaker; 6. Under absolute isolation (such as open or infectious pulmonary tuberculosis);

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Post-extubation dysphagia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Deglutition Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Zhongnan hospital of Wuhan University, Wuhan, Hubei 430070

    Wuhan, Hubei, 430070, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.